HK $309 million of Hong Kong shares were bought by Beishui (Shanghai) stock connect, of which HK $1.059 billion was bought by Beishui (Shanghai) stock connect on the net.
Beishuijing bought the most stocks are China Mobile (00941), Li Ning (02331) and meituan-w (03690). The most sold stocks of beishuijing are China Resources Power (00836), Semiconductor Manufacturing International Corporation(688981) (00981) and Yaoming Biology (02269).
Top 10 active trading stocks of Hong Kong stock connect (Shanghai)
Top 10 active trading stocks of Hong Kong stock connect (Shenzhen)
China Mobile (00941) received a net purchase of HK $229 million. Xiaomo released a research report saying that it maintained the “overweight” rating of China Telecom Corporation Limited(601728) , with a target price of HK $3.7. Maintain China Telecom Corporation Limited(601728) as the preferred stock in the industry. According to the report, China Telecom Corporation Limited(601728) aims to achieve double-digit revenue and profit growth in 2022, mainly driven by the strong growth of industrial digital business. The management expects that 5g will continue to increase mobile service revenue in the next two years, and assumes that the ratio of capital expenditure to revenue will fall to less than 20% by 2025. The bank pointed out that despite the increase in industrial digital investment, China Telecom Corporation Limited(601728) will increase its dividend ratio from 40% in 2020 to 60% last year, and is expected to reach at least 70% in 2023, with a dividend rate of 9%.
Li Ning (02331) received another net purchase of HK $147 million. In terms of news, Li Ning previously announced its annual results. During the period, the company’s revenue was 22.572 billion yuan, a year-on-year increase of 56.13%; The profit attributable to equity holders of the company was 4.011 billion yuan, a year-on-year increase of 136.14%. It means that the revenue and net profit in the second half of 2021 will increase by 50% and 102% respectively. A number of major banks said Li Ning’s performance exceeded expectations.
Kwai -W (01024) was net purchase of HK $122 million. On the news side, Citic Securities Company Limited(600030) issued Research Report, maintained Kwai Kong target price HK $160, maintain “buy” rating. Optimistic about the growth momentum of the platform ecology and commercialization, as China’s short head video platform, Kwai is expected to continuously optimize the product model, content strategy and commercialization to achieve revenue breakthroughs and net losses.
Rongchuang China (01918) received another net purchase of HK $118 million. In terms of news, the financial commission of the State Council previously said that it was necessary to timely study and put forward effective solutions to prevent and resolve risks, and put forward supporting measures for the transformation to a new development model; The cbcirc said that it encouraged institutions to carry out M & A loans in a stable and orderly manner, and focused on supporting high-quality real estate enterprises to merge and acquire high-quality projects of difficult real estate enterprises; The Ministry of Finance said that it is not qualified to expand the pilot cities of real estate tax reform this year.
Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) (02196) received a net purchase of HK $43.8 million. On the news side, Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) will hold a board meeting on March 22 to consider and adopt the annual performance of the company and its subsidiaries for the year ended December 31, 2021. In addition, Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) recently welcomes multiple profits Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) holding subsidiary obtained the non exclusive license for the production of oral covid-19 drug nimatovir and nimatovir / ritonavir combination Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) announced that Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) industry, a holding subsidiary, has received the approval of the State Food and drug administration to conduct a clinical trial of svn53-67 / m57-klh peptide vaccine (survaxm) combined with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma.
China Resources Power (00836) was sold net of HK $114 million. In terms of news, Bank of America Securities issued a report that the average price of 5500 kcal thermal coal in Qinhuangdao remained high in the first two months of this year, reaching 1096 yuan per ton, higher than the bank’s forecast of 770 yuan per ton this year. China Resources power needs to increase the market sales price by more than 16%, or reduce the average coal price by more than 25%, so that the earnings per share performance can be better than the bank’s expectations. The group said that the market sales electricity price increased by 10% in the first two months, lower than the bank’s forecast of 16% this year. The target price of China Resources Power was lowered from HK $19 to HK $18.8, and the rating remained “buy”.
In addition, meituan-w (03690), Tencent (00700) and CNOOC (00883) received net purchases of HK $129 million, HK $72.38 million and HK $68.54 million respectively. While Semiconductor Manufacturing International Corporation(688981) (00981) and Yaoming biological (02269) were sold net of HK $62.27 million and HK $49.88 million respectively.
